{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-22-000042","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2022-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.730184+00:00","generated_at":"2026-06-22T05:15:05.129232+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SI-BONE posts Q3 2022 record revenue of $26.4M, up 19% YoY; guides FY22 revenue $104-105M","bullets":["Worldwide revenue $26.4M (+19% YoY); U.S. revenue $24.6M (+21% YoY).","Gross margin 84% vs 89% YoY, pressured by product mix, lower ASPs, and higher freight.","Net loss $14.2M ($0.41/share) vs $15.9M ($0.48/share) in prior year.","FY2022 revenue guidance raised to $104-105M (16-17% growth); implies Q4 of $29.5-30.5M.","Over 800 U.S. active surgeons (+27% YoY); CMS finalized ~26-33% Medicare facility fee hike for 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-22-000042","json":"https://secwatch.observer/filing/0001459839-22-000042.json","markdown":"https://secwatch.observer/filing/0001459839-22-000042.md","text":"https://secwatch.observer/filing/0001459839-22-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/0001459839-22-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/sibn-20221107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T05:15:05.129232+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"af18e32b5cc4268f2484b821b6f4238884e41b09","claim":"SI-BONE, Inc. reported the quarter ended September 30, 2022 results: revenue $26.4 million, net income $14.2 million, EPS $0.41 per diluted share.","evidence_excerpt":"musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2022. Recent Highlights • Record world wide revenue of $26.4 million for the third quarter 2022, representing approximately 19% increase over the corresponding period in 2021 • Record U.S. revenue of $24.6 million for the third quarter 2022,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/0001459839-22-000042-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022"},{"label":"Revenue","value":"$26.4 million"},{"label":"Net income","value":"$14.2 million"},{"label":"EPS","value":"$0.41 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}